Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26906745
DOI
10.1530/joe-15-0519
PII: JOE-15-0519
Knihovny.cz E-zdroje
- Klíčová slova
- ZDF rats, diet-induced obesity, food intake, lipidization, prolactin-releasing peptide, rat,
- MeSH
- anorektika farmakologie MeSH
- dieta s vysokým obsahem tuků škodlivé účinky MeSH
- experimentální diabetes mellitus metabolismus MeSH
- glukózový toleranční test MeSH
- hormon uvolňující prolaktin analogy a deriváty farmakologie MeSH
- játra účinky léků metabolismus MeSH
- krysa rodu Rattus MeSH
- leptinové receptory nedostatek MeSH
- lipoylace MeSH
- messenger RNA genetika metabolismus MeSH
- metabolismus lipidů účinky léků genetika MeSH
- myši MeSH
- obezita farmakoterapie metabolismus patologie MeSH
- potkani Sprague-Dawley MeSH
- potkani Zucker MeSH
- přijímání potravy účinky léků MeSH
- racionální návrh léčiv MeSH
- tělesná hmotnost účinky léků MeSH
- tuková tkáň účinky léků metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- anorektika MeSH
- hormon uvolňující prolaktin MeSH
- leptinové receptory MeSH
- messenger RNA MeSH
Anorexigenic neuropeptides produced and acting in the brain have the potential to decrease food intake and ameliorate obesity, but are ineffective after peripheral application, owing to a limited ability to cross the blood-brain barrier. We have designed lipidized analogs of prolactin-releasing peptide (PrRP), which is involved in energy balance regulation as demonstrated by obesity phenotypes of both Prrp-knockout and Prrp receptor-knockout mice. The aim of this study was to characterize the subchronic effect of a palmitoylated PrRP analog in two rat models of obesity and diabetes: diet-induced obese Sprague-Dawley rats and leptin receptor-deficient Zucker diabetic (ZDF) rats. In the rats with diet-induced obesity (DIO), a two-week intraperitoneal treatment with palmitoylated PrRP lowered food intake by 24% and body weight by 8%. This treatment also improved glucose tolerance and tended to decrease leptin levels and adipose tissue masses in a dose-dependent manner. In contrast, in ZDF rats, the same treatment with palmitoylated PrRP lowered food intake but did not significantly affect body weight or glucose tolerance, probably in consequence of severe leptin resistance due to a nonfunctional leptin receptor. Our data indicate a good efficacy of lipidized PrRP in DIO rats. Thus, the strong anorexigenic, body weight-reducing, and glucose tolerance-improving effects make palmitoylated PrRP an attractive candidate for anti-obesity treatment.
1st Faculty of MedicineCharles University Prague Czech Republic
Citace poskytuje Crossref.org
Prolactin-Releasing Peptide: Physiological and Pharmacological Properties
